Category Archives: Central and Eastern Europe
Promising Interim Clinical Data for NOX66
Below, we are re-publishing with permission the press-release issued by Noxopharm Limited on the 20th of November 2017 PROMISING INTERIM CLINICAL DATA FOR NOX66 Patients with metastatic, late-stage cancers 10 of 11 patients showing no disease progression following 3-months treatment with NOX66 … Continue reading
REPLICOR’S NEW PHASE II TRIAL CONDUCTED BY CLINICAL ACCELERATOR PRODUCES EXCITING CLINICAL DATA FOR THEIR NUCLEIC ACID POLYMER (NAP) DRUG REP 2139-CA FOR PATIENTS WITH HBV / HDV CO-INFECTION.
In December last year a Clinical Accelerator post (1) reported that recruitment was underway in Moldova for an interesting Phase II trial of Replicor’s novel nucleic acid polymer (NAP), REP 2139-Ca, in combination with the immunotherapeutic agent, pegylated interferon alfa-2a … Continue reading
IQPC finally recognizes the value of Eastern Europe for clinical trials
You don’t say! Packed with eager, treatment naive participants, and short of the many transportation complexities faced in little established research sites, Eastern Europe is becoming increasingly recognised as among the best places to conduct a clinical trial. The surprise … Continue reading
Posted in Central and Eastern Europe
Leave a comment
Completion of D-Pharm’s Phase II trial for stroke patients in Ukraine
Clinical Accelerator is pleased to announce the timely completion of an interesting trial it has been conducting for D-Pharm in patients with ischaemic stroke at the State Medical Preventive Institution “Central Clinical Hospital of Ukrzaliznytsia”, Kharkov, Ukraine (1). This study … Continue reading
Clinical trials in Poland
At Clinical Accelerator we conduct many of our trials in Central and Eastern Europe, and it’s important to us that we monitor the latest data coming for our countries of operation. We’re pleased to see that, based on recent statistics, … Continue reading
Posted in Central and Eastern Europe
Leave a comment
How to improve and retain the participation of minorities in clinical trials – lessons learned from the Maryland Regional Community Network Program
Challenges in recruiting patients from minorities Successfully recruiting ethnic minorities into clinical trials is a major challenge for healthcare professionals. There are obvious benefits to the individual and their community, and to the integrity of scientific research through the diversity … Continue reading
Creating culturally appropriate enrolment approaches for education and retention of patients in clinical trials in Eastern Europe
Difficulties in recruiting patients One of the biggest problems in conducting clinical trials successfully is patient recruitment. Another challenge is assuring diversity in clinical trials enrolment which is essential for eliminating health disparities as low enrollment and participation of racial/ethnic minorities … Continue reading
